CONGENITAL TOXOPLASMOSIS: CLINICAL COURSE AND RESIDUAL OUTCOMES
https://doi.org/10.22627/2072-8107-2014-13-2-52-56
Abstract
We examined 69 infants with clinically manifested forms of congenital toxoplasmosis diagnosed in theStavropolregion in the period from 1992 to 2012. The clinical course was characterized by a predominance of severe forms of congenial toxoplasmosis, high mortality rate (39,1%), predominant damage the central nervous system (100%) and adverse neurological outcome. Surviving children developed disabilities at the outcome of congenital toxoplasmosis such as hydrocephaly (71,4%), microcephaly (9,5%), cerebral palsy (52,4%), episindroma (16,7%), mental retardation (19,0 %) complete or partial blindness (28,6%).
About the Authors
L. Yu. Barycheva
Stavropol State Medical University
Russian Federation
Russian Federation
M. V. Golubeva
Stavropol State Medical University
Russian Federation
Russian Federation
M. A. Kabulova
Stavropol State Medical University
Russian Federation
Russian Federation
I. V. Kostornaya
Stavropol State Medical University
Russian Federation
Russian Federation
References
1. Why prevent, diagnose and treat congenital toxoplasmosis? / R. McLeod [et al.] // Mem Inst Oswaldo Cruz. — 2009. — № 104 (2). — P. 320—344.
2. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance / F. Peyron [et. al.] // Pediatr Infect Dis J. — 2011. — № 30 (7). — P. 597—600.
3. McLeod R. Toxoplasmosis / R. McLeod, J. S. Remington // Nelson’s Textbook of Pediatrics. 18th ed. Philadelphia: WB Saunders / editors R.L Behrman RL. — 2006. — P. 1486—1495.
4. Долгих Т.И. Токсоплазмоз: современные стратегии лабораторной диагностики // Инфекция и иммунитет. — 2011. — Т. 1. — № 1. — С. 43—50.
5. Bénard A. Systematic review of published data on the burden of congenital toxoplasmosis in Europe. European TOXO PREVENTION Projec. 2006 / A. Bénard, L. R. Salmi Available at: (accessed 20 October 2006).
6. Neonatal screening for congenital toxoplasmosis in the Poznań region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots / M. Paul [et al.] // Pediatr Infect Dis J. — 2000. — № 19 (1). — P. 30—36.
7. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982—1999 / L.M. Signorell [et al.] // Pediatr Infect Dis J. — 2006. — № 25 (2). — P. 123—128.
8. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999— 2002 / D.R. Schmidt [et. al] // Arch Dis Child. — 2006. — № 91 (8). — P. 661—665.
9. Toxosurv network and National Reference Centre for Toxoplasmosis. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system / I. Villena [et. al.] // Euro Surveill. — 2010. — 15 (25): pii = 19600. Available online: http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId = 19600.
10. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden / B. Evengard [et al.] // Epidemiol Infect. — 2001. — № 127 (1). — P. 121—127.
11. Иванова И.Б. Токсоплазмоз на территории г. Хабаровска (лабораторная диагностика и интерпретация результатов) / И.Б. Иванова, С.А. Кузнецова // Журнал Инфекционной патологии. — 2009. — № 14. — С. 69—73.
12. Барычева Л.Ю. Клинические и иммунологические особенности врожденного токсоплазмоза // Российский вестник перинатологии и педиатрии. — 2004. — Т. 49. — № 2. — С. 55—59.
13. Орехов К.В. Формирование системы иммунитета у детей с врожденными инфекциями: Монография / К.В. Орехов, Л.Ю. Барычева. — Ставрополь, 2006. — 130 с.
14. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe / R.E. Gilbert [et al.] // PloS Negl Trop Dis. — P. 2008. — № 2 (8). — e277.
15. Congenital toxoplasmosis: clinical, laboratory and therapeutic considerations, with special reference to subclinical disease // C. J. Alford, S. Stagno, D.W. Reynolds // Bull N Y Acad Med. — 1974. — № 50. — P. 160—181.
Review
For citations:
Barycheva L.Yu., Golubeva M.V., Kabulova M.A., Kostornaya I.V. CONGENITAL TOXOPLASMOSIS: CLINICAL COURSE AND RESIDUAL OUTCOMES. CHILDREN INFECTIONS. 2014;13(2):52-56. (In Russ.) https://doi.org/10.22627/2072-8107-2014-13-2-52-56
Views:
860
Email this article 